Lonza to Expand Early Development Services Offering into North America

Date Published02/13/2023
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Lonza Biologics Inc
Parent companyLonza Group
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2023
Year reshoring implemented or to be implemented:2023
Country(ies) from which reshored:Switzerland
City reshored to:Cambridge
State(s) reshored to:MA
If relevant, work nearshored to:-
Product(s) reshoredpharma, biotech
What domestic positive factors made reshoring more attractive?Infrastructure, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market
Find Reshoring Articles